Cardio Diagnostics Holdings is trading at $2.05 (+9.63%), with no fresh company-specific announcement identified to explain the October 12 pre-market rise. - The company’s $854 final CMS payment rate is older news, not a new overnight catalyst. - Healthcare-sector sentiment may be supportive after Humana rallied on improved Medicare Advantage ratings, but that does not establish a direct cause for this move. - Supplied market indicators were mixed; pre-market volume or activity details were unavailable.